 Christopher Hoyte
Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poison Control Centers | 15 | 2025 | 90 | 5.540 |
Why?
| | Acetaminophen | 9 | 2023 | 268 | 2.130 |
Why?
| | Poisons | 5 | 2023 | 23 | 2.090 |
Why?
| | Antivenins | 8 | 2025 | 36 | 2.060 |
Why?
| | Toxicology | 4 | 2025 | 48 | 1.890 |
Why?
| | Analgesics, Non-Narcotic | 5 | 2023 | 125 | 1.730 |
Why?
| | Snake Bites | 6 | 2025 | 29 | 1.570 |
Why?
| | Drug Overdose | 8 | 2024 | 347 | 1.470 |
Why?
| | Biguanides | 2 | 2023 | 12 | 1.410 |
Why?
| | Cannabis | 6 | 2023 | 494 | 1.330 |
Why?
| | Antidotes | 3 | 2022 | 143 | 1.210 |
Why?
| | Anaphylaxis | 3 | 2023 | 105 | 1.110 |
Why?
| | Chemical and Drug Induced Liver Injury | 3 | 2022 | 137 | 0.960 |
Why?
| | Spider Venoms | 2 | 2017 | 11 | 0.940 |
Why?
| | Emergency Service, Hospital | 9 | 2023 | 2069 | 0.930 |
Why?
| | Anticonvulsants | 2 | 2019 | 217 | 0.930 |
Why?
| | Methadone | 2 | 2023 | 101 | 0.920 |
Why?
| | Education, Distance | 1 | 2025 | 50 | 0.910 |
Why?
| | Hydrazines | 1 | 2024 | 35 | 0.870 |
Why?
| | Energy Drinks | 2 | 2013 | 4 | 0.840 |
Why?
| | Simulation Training | 1 | 2025 | 106 | 0.830 |
Why?
| | Substance-Related Disorders | 3 | 2019 | 1083 | 0.830 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2025 | 135 | 0.830 |
Why?
| | Hypoglycemic Agents | 3 | 2025 | 1291 | 0.810 |
Why?
| | Viper Venoms | 3 | 2021 | 9 | 0.810 |
Why?
| | Prescription Drugs | 2 | 2015 | 109 | 0.790 |
Why?
| | Abdominal Pain | 3 | 2023 | 145 | 0.770 |
Why?
| | Analgesia | 1 | 2023 | 94 | 0.760 |
Why?
| | Adolescent | 26 | 2025 | 21513 | 0.760 |
Why?
| | Retrospective Studies | 26 | 2025 | 15657 | 0.750 |
Why?
| | Education, Medical | 1 | 2025 | 266 | 0.750 |
Why?
| | Machine Learning | 3 | 2023 | 493 | 0.750 |
Why?
| | Ethylene Glycol | 1 | 2021 | 13 | 0.740 |
Why?
| | Metformin | 3 | 2022 | 331 | 0.730 |
Why?
| | Designer Drugs | 2 | 2019 | 8 | 0.730 |
Why?
| | United States | 19 | 2025 | 14841 | 0.710 |
Why?
| | Young Adult | 20 | 2025 | 13209 | 0.700 |
Why?
| | Databases, Factual | 2 | 2023 | 1357 | 0.680 |
Why?
| | Alcoholic Intoxication | 1 | 2021 | 68 | 0.680 |
Why?
| | Occupational Exposure | 1 | 2024 | 341 | 0.670 |
Why?
| | Spider Bites | 2 | 2017 | 9 | 0.660 |
Why?
| | Black Widow Spider | 2 | 2017 | 9 | 0.660 |
Why?
| | Cannabinoids | 4 | 2018 | 161 | 0.650 |
Why?
| | Humans | 63 | 2025 | 137585 | 0.650 |
Why?
| | Hyperammonemia | 1 | 2019 | 16 | 0.620 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 35 | 0.620 |
Why?
| | Acetylcysteine | 2 | 2022 | 145 | 0.610 |
Why?
| | Garlic | 1 | 2019 | 4 | 0.610 |
Why?
| | Occlusive Dressings | 1 | 2019 | 5 | 0.610 |
Why?
| | Warts | 1 | 2019 | 6 | 0.610 |
Why?
| | Valproic Acid | 1 | 2019 | 48 | 0.610 |
Why?
| | Foot Diseases | 1 | 2019 | 15 | 0.610 |
Why?
| | Heart Arrest | 3 | 2023 | 339 | 0.600 |
Why?
| | Venoms | 1 | 2018 | 29 | 0.600 |
Why?
| | Carnitine | 1 | 2019 | 84 | 0.590 |
Why?
| | Bites and Stings | 1 | 2018 | 32 | 0.590 |
Why?
| | Burns, Chemical | 1 | 2019 | 32 | 0.590 |
Why?
| | Seizures | 3 | 2024 | 426 | 0.590 |
Why?
| | Foot Injuries | 1 | 2019 | 25 | 0.590 |
Why?
| | Male | 34 | 2025 | 67762 | 0.580 |
Why?
| | Brain Diseases | 1 | 2019 | 141 | 0.560 |
Why?
| | Pyridoxine | 1 | 2018 | 36 | 0.560 |
Why?
| | Vitamin B Complex | 1 | 2018 | 44 | 0.550 |
Why?
| | Isoniazid | 1 | 2018 | 63 | 0.550 |
Why?
| | Abdominal Injuries | 1 | 2019 | 123 | 0.540 |
Why?
| | Dronabinol | 3 | 2023 | 226 | 0.540 |
Why?
| | Adult | 25 | 2025 | 37929 | 0.540 |
Why?
| | Decision Trees | 5 | 2023 | 93 | 0.530 |
Why?
| | Electrocardiography | 3 | 2024 | 629 | 0.510 |
Why?
| | Acidosis | 3 | 2024 | 101 | 0.510 |
Why?
| | Pain Measurement | 1 | 2018 | 521 | 0.500 |
Why?
| | Renal Insufficiency | 1 | 2018 | 162 | 0.500 |
Why?
| | Antitubercular Agents | 1 | 2018 | 206 | 0.490 |
Why?
| | Child, Preschool | 14 | 2024 | 11074 | 0.490 |
Why?
| | Piracetam | 1 | 2015 | 13 | 0.470 |
Why?
| | Phenethylamines | 1 | 2015 | 23 | 0.470 |
Why?
| | Sodium Channel Blockers | 1 | 2015 | 24 | 0.470 |
Why?
| | Amitriptyline | 1 | 2015 | 21 | 0.470 |
Why?
| | Hallucinations | 1 | 2015 | 29 | 0.470 |
Why?
| | Female | 29 | 2025 | 73304 | 0.470 |
Why?
| | Sports | 2 | 2015 | 231 | 0.470 |
Why?
| | Tachycardia | 1 | 2015 | 57 | 0.470 |
Why?
| | Epilepsy | 2 | 2019 | 333 | 0.460 |
Why?
| | Sodium Channels | 1 | 2015 | 65 | 0.460 |
Why?
| | Food | 1 | 2016 | 164 | 0.460 |
Why?
| | Acetamides | 1 | 2015 | 36 | 0.460 |
Why?
| | Israel | 5 | 2025 | 56 | 0.460 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 63 | 0.460 |
Why?
| | Child | 22 | 2025 | 21935 | 0.450 |
Why?
| | Long QT Syndrome | 1 | 2015 | 70 | 0.440 |
Why?
| | Crotalid Venoms | 2 | 2025 | 31 | 0.410 |
Why?
| | Performance-Enhancing Substances | 1 | 2013 | 10 | 0.410 |
Why?
| | Analgesics, Opioid | 4 | 2023 | 1000 | 0.410 |
Why?
| | Tachycardia, Ventricular | 1 | 2015 | 175 | 0.410 |
Why?
| | Diet Surveys | 1 | 2013 | 95 | 0.400 |
Why?
| | Caffeine | 1 | 2013 | 68 | 0.400 |
Why?
| | Ethylene Glycols | 1 | 2012 | 16 | 0.390 |
Why?
| | Hallucinogens | 2 | 2024 | 105 | 0.370 |
Why?
| | Middle Aged | 15 | 2025 | 33479 | 0.360 |
Why?
| | Athletes | 1 | 2015 | 423 | 0.360 |
Why?
| | Hypoglycemia | 3 | 2025 | 445 | 0.330 |
Why?
| | Vomiting | 3 | 2022 | 130 | 0.320 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2025 | 2531 | 0.300 |
Why?
| | Infant | 8 | 2022 | 9465 | 0.290 |
Why?
| | Aged | 11 | 2025 | 23961 | 0.290 |
Why?
| | Infusions, Intravenous | 2 | 2019 | 413 | 0.280 |
Why?
| | Crotalus | 2 | 2025 | 26 | 0.270 |
Why?
| | Incidence | 3 | 2021 | 2804 | 0.270 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2023 | 249 | 0.270 |
Why?
| | Poisoning | 3 | 2024 | 120 | 0.260 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3284 | 0.250 |
Why?
| | Prognosis | 4 | 2022 | 4030 | 0.250 |
Why?
| | Sulfonylurea Compounds | 2 | 2023 | 48 | 0.240 |
Why?
| | Tertiary Healthcare | 3 | 2024 | 33 | 0.240 |
Why?
| | Glyoxylates | 1 | 2025 | 10 | 0.240 |
Why?
| | Hair Preparations | 1 | 2025 | 8 | 0.240 |
Why?
| | Colorado | 5 | 2019 | 4565 | 0.240 |
Why?
| | Physical Examination | 2 | 2018 | 241 | 0.240 |
Why?
| | India | 1 | 2025 | 195 | 0.230 |
Why?
| | Animals | 12 | 2025 | 36940 | 0.220 |
Why?
| | Hospitals, Teaching | 1 | 2024 | 118 | 0.220 |
Why?
| | Viperidae | 2 | 2021 | 7 | 0.220 |
Why?
| | Drug Costs | 1 | 2025 | 106 | 0.220 |
Why?
| | Glucagon-Like Peptides | 1 | 2025 | 58 | 0.210 |
Why?
| | Plant Poisoning | 1 | 2023 | 9 | 0.210 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2025 | 201 | 0.210 |
Why?
| | Treatment Outcome | 5 | 2019 | 10811 | 0.210 |
Why?
| | Benzodiazepines | 3 | 2023 | 155 | 0.200 |
Why?
| | Educational Measurement | 1 | 2025 | 289 | 0.200 |
Why?
| | Epinephrine | 1 | 2023 | 139 | 0.200 |
Why?
| | Support Vector Machine | 1 | 2022 | 38 | 0.190 |
Why?
| | Foodborne Diseases | 1 | 2023 | 57 | 0.190 |
Why?
| | Algorithms | 4 | 2023 | 1704 | 0.190 |
Why?
| | Medicine | 1 | 2024 | 121 | 0.190 |
Why?
| | Health Facilities | 1 | 2022 | 84 | 0.190 |
Why?
| | Referral and Consultation | 2 | 2024 | 786 | 0.180 |
Why?
| | Health Care Costs | 1 | 2025 | 398 | 0.180 |
Why?
| | Cohort Studies | 3 | 2022 | 5742 | 0.180 |
Why?
| | Age Factors | 2 | 2021 | 3295 | 0.180 |
Why?
| | Fentanyl | 1 | 2022 | 94 | 0.180 |
Why?
| | Computer Simulation | 1 | 2025 | 978 | 0.170 |
Why?
| | Hospitals, Pediatric | 3 | 2019 | 508 | 0.170 |
Why?
| | Students, Medical | 1 | 2025 | 348 | 0.170 |
Why?
| | Anesthesia | 1 | 2023 | 189 | 0.170 |
Why?
| | Tramadol | 1 | 2020 | 14 | 0.170 |
Why?
| | Prevalence | 2 | 2019 | 2734 | 0.170 |
Why?
| | Pain Management | 1 | 2023 | 352 | 0.160 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 250 | 0.160 |
Why?
| | Drug Administration Schedule | 2 | 2019 | 786 | 0.160 |
Why?
| | Bacitracin | 1 | 2019 | 6 | 0.150 |
Why?
| | Mediterranean Sea | 1 | 2018 | 1 | 0.150 |
Why?
| | Mortality | 1 | 2021 | 362 | 0.150 |
Why?
| | Regression Analysis | 1 | 2021 | 1024 | 0.150 |
Why?
| | Scyphozoa | 1 | 2018 | 3 | 0.150 |
Why?
| | North America | 3 | 2025 | 313 | 0.150 |
Why?
| | Medicine, Traditional | 1 | 2019 | 24 | 0.150 |
Why?
| | Ammonia | 1 | 2019 | 62 | 0.150 |
Why?
| | Hyperlactatemia | 1 | 2018 | 3 | 0.150 |
Why?
| | Bandages | 1 | 2019 | 37 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2019 | 40 | 0.150 |
Why?
| | Debridement | 1 | 2019 | 81 | 0.150 |
Why?
| | Drug Packaging | 1 | 2019 | 45 | 0.150 |
Why?
| | Registries | 5 | 2025 | 2035 | 0.140 |
Why?
| | Medical Marijuana | 1 | 2020 | 117 | 0.140 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2018 | 45 | 0.140 |
Why?
| | Cannabidiol | 1 | 2020 | 119 | 0.140 |
Why?
| | Clinical Competence | 1 | 2025 | 1118 | 0.140 |
Why?
| | Lead | 1 | 2018 | 64 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2025 | 815 | 0.140 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 87 | 0.140 |
Why?
| | Blood Coagulation | 1 | 2019 | 255 | 0.140 |
Why?
| | Liver Failure, Acute | 1 | 2018 | 67 | 0.130 |
Why?
| | Clinical Protocols | 1 | 2019 | 271 | 0.130 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 220 | 0.130 |
Why?
| | Administration, Intravenous | 1 | 2018 | 155 | 0.130 |
Why?
| | Physician's Role | 1 | 2018 | 211 | 0.130 |
Why?
| | Preventive Health Services | 1 | 2018 | 148 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2844 | 0.120 |
Why?
| | Seasons | 1 | 2018 | 547 | 0.120 |
Why?
| | Acute Disease | 1 | 2019 | 1007 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 179 | 0.120 |
Why?
| | Serotonin Syndrome | 1 | 2015 | 4 | 0.120 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1066 | 0.120 |
Why?
| | Clozapine | 1 | 2015 | 20 | 0.120 |
Why?
| | Serotonin Antagonists | 1 | 2015 | 32 | 0.120 |
Why?
| | Sertraline | 1 | 2015 | 29 | 0.120 |
Why?
| | Age Distribution | 1 | 2016 | 392 | 0.120 |
Why?
| | Internship and Residency | 1 | 2025 | 1147 | 0.120 |
Why?
| | Mental Disorders | 1 | 2024 | 1077 | 0.110 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2015 | 46 | 0.110 |
Why?
| | Sodium Bicarbonate | 1 | 2015 | 45 | 0.110 |
Why?
| | Marijuana Use | 1 | 2018 | 206 | 0.110 |
Why?
| | Hemorrhage | 1 | 2019 | 722 | 0.110 |
Why?
| | Critical Illness | 1 | 2020 | 811 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2020 | 560 | 0.100 |
Why?
| | Drug Interactions | 1 | 2015 | 410 | 0.100 |
Why?
| | Physician-Patient Relations | 1 | 2018 | 548 | 0.100 |
Why?
| | Indazoles | 1 | 2014 | 69 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1040 | 0.100 |
Why?
| | Hospital Mortality | 3 | 2023 | 911 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2018 | 530 | 0.100 |
Why?
| | Lithium | 2 | 2023 | 43 | 0.100 |
Why?
| | Diphenhydramine | 2 | 2023 | 37 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2022 | 7635 | 0.100 |
Why?
| | Risk Factors | 3 | 2015 | 10388 | 0.100 |
Why?
| | Immunoglobulin G | 1 | 2017 | 893 | 0.100 |
Why?
| | Calcium Channel Blockers | 2 | 2023 | 167 | 0.090 |
Why?
| | Athletic Performance | 1 | 2013 | 79 | 0.090 |
Why?
| | Suicide, Attempted | 1 | 2015 | 378 | 0.090 |
Why?
| | Firearms | 1 | 2018 | 386 | 0.090 |
Why?
| | Horses | 2 | 2022 | 111 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1468 | 0.080 |
Why?
| | Universities | 1 | 2013 | 433 | 0.080 |
Why?
| | Infant, Newborn | 2 | 2022 | 6079 | 0.080 |
Why?
| | Data Collection | 1 | 2013 | 673 | 0.080 |
Why?
| | Eating | 2 | 2023 | 380 | 0.080 |
Why?
| | Blood Glucose | 1 | 2020 | 2186 | 0.080 |
Why?
| | Mass Screening | 1 | 2018 | 1287 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 2015 | 552 | 0.080 |
Why?
| | Pyrazoles | 1 | 2012 | 423 | 0.070 |
Why?
| | Students | 1 | 2013 | 622 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1738 | 0.070 |
Why?
| | Pilot Projects | 2 | 2023 | 1710 | 0.070 |
Why?
| | Shoulder Dislocation | 1 | 2008 | 49 | 0.070 |
Why?
| | Naloxone | 2 | 2020 | 122 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 2071 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 6828 | 0.070 |
Why?
| | Nortriptyline | 1 | 2024 | 10 | 0.050 |
Why?
| | Quetiapine Fumarate | 1 | 2024 | 23 | 0.050 |
Why?
| | Xenobiotics | 1 | 2024 | 32 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 31 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 160 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 55 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2023 | 68 | 0.050 |
Why?
| | Bupropion | 1 | 2022 | 45 | 0.050 |
Why?
| | Documentation | 1 | 2024 | 194 | 0.050 |
Why?
| | Guidelines as Topic | 1 | 2024 | 275 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 306 | 0.050 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2022 | 59 | 0.050 |
Why?
| | Vertigo | 1 | 2022 | 39 | 0.050 |
Why?
| | Nausea | 1 | 2022 | 111 | 0.050 |
Why?
| | Tremor | 1 | 2022 | 65 | 0.050 |
Why?
| | Dizziness | 1 | 2022 | 82 | 0.050 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2023 | 323 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2024 | 333 | 0.040 |
Why?
| | Diarrhea | 1 | 2022 | 184 | 0.040 |
Why?
| | Consensus | 1 | 2024 | 683 | 0.040 |
Why?
| | Coma | 1 | 2020 | 32 | 0.040 |
Why?
| | Mice | 1 | 2018 | 17787 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5778 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7604 | 0.040 |
Why?
| | Nomograms | 1 | 2020 | 54 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 499 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2020 | 66 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2024 | 740 | 0.040 |
Why?
| | Aspirin | 1 | 2022 | 387 | 0.040 |
Why?
| | Sheep | 1 | 2022 | 856 | 0.040 |
Why?
| | Hospitals | 1 | 2024 | 691 | 0.040 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 318 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 347 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 1069 | 0.030 |
Why?
| | Edema | 1 | 2017 | 130 | 0.030 |
Why?
| | Near Drowning | 1 | 2015 | 1 | 0.030 |
Why?
| | Exercise | 1 | 2008 | 2057 | 0.030 |
Why?
| | Cardiac Tamponade | 1 | 2015 | 12 | 0.030 |
Why?
| | Hypotension | 1 | 2017 | 122 | 0.030 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2015 | 30 | 0.030 |
Why?
| | Hypothermia | 1 | 2015 | 36 | 0.030 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2015 | 77 | 0.030 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2015 | 44 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 226 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5472 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2057 | 0.020 |
Why?
| | Pain | 1 | 2017 | 756 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 395 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2199 | 0.020 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2015 | 480 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 758 | 0.020 |
Why?
| | Manipulation, Orthopedic | 1 | 2008 | 7 | 0.020 |
Why?
| | Shoulder Pain | 1 | 2008 | 34 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2668 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2008 | 102 | 0.020 |
Why?
| | Radiography | 1 | 2008 | 822 | 0.010 |
Why?
| | Pregnancy | 1 | 2015 | 6763 | 0.010 |
Why?
| | Athletic Injuries | 1 | 2008 | 529 | 0.010 |
Why?
|
|
Hoyte's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|